Table 3 Clinical features and therapeutic management of patients in the DM group (n = 39) based on initial presentation with DM (n = 12) or development of DM after initial diagnosis (n = 27)
Variable | Presented with DM n (%) | Developed DM after diagnosis n (%) | Total n (%) |
|---|---|---|---|
Presenting Symptom | |||
Pathological fracture | 7 (58) | _ | _ |
Pulmonary symptoms or incidental lung nodules | 5 (42) | _ | _ |
Presenting site of DM | |||
Lung | 5 (42) | 19 (70) | 24 (62) |
Bone | 7 (58) | 5 (19) | 12 (31) |
Brain | 0 (0) | 1 (3) | 1 (3) |
Mediastinum | 0 (0) | 1 (3) | 1 (3) |
Multiple sites | 1 (3) | 0 (0) | 1 (3) |
Multiple sites of DM | 8 (67) | 10 (37) | 18 (46) |
Treatment | |||
1 RAI cycle | 12 (100) | 27 (100) | 39 (100) |
> 1 RAI cycle | 6 (50) | 11 (41) | 17 (44) |
EBRT | 10 (83) | 12 (44) | 22 (56) |
Metastectomy | 7 (58) | 6 (22) | 13 (33) |